Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • Equity, Diversity, and Inclusion
    • Innovations in Care Delivery
    • Without Borders
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
    • Article CME
    • Podcast CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • Equity, Diversity, and Inclusion
    • Innovations in Care Delivery
    • Without Borders
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
    • Article CME
    • Podcast CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Articles
  • Issues

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Neurology Genetics
Home
A peer-reviewed clinical and translational neurology open access journal
  • My alerts
  • Log in
Site Logo
  • Home
  • Articles
  • Issues

Share

December 2019; 5 (6) Clinical/Scientific NotesOpen Access

Further supporting evidence for REEP1 phenotypic and allelic heterogeneity

View ORCID ProfileReza Maroofian, View ORCID ProfileMahdiyeh Behnam, View ORCID ProfileRauan Kaiyrzhanov, View ORCID ProfileVincenzo Salpietro, View ORCID ProfileMansour Salehi, View ORCID ProfileHenry Houlden
First published November 15, 2019, DOI: https://doi.org/10.1212/NXG.0000000000000379
Reza Maroofian
From the Department of Neuromuscular Disorders Institute of Neurology (R.M., R.K., V.S., H.H.), University College London, Queen Square; and Medical Genetics Laboratory of Genome (M.B., M.S.), Isfahan, Iran.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Reza Maroofian
Mahdiyeh Behnam
From the Department of Neuromuscular Disorders Institute of Neurology (R.M., R.K., V.S., H.H.), University College London, Queen Square; and Medical Genetics Laboratory of Genome (M.B., M.S.), Isfahan, Iran.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mahdiyeh Behnam
Rauan Kaiyrzhanov
From the Department of Neuromuscular Disorders Institute of Neurology (R.M., R.K., V.S., H.H.), University College London, Queen Square; and Medical Genetics Laboratory of Genome (M.B., M.S.), Isfahan, Iran.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rauan Kaiyrzhanov
Vincenzo Salpietro
From the Department of Neuromuscular Disorders Institute of Neurology (R.M., R.K., V.S., H.H.), University College London, Queen Square; and Medical Genetics Laboratory of Genome (M.B., M.S.), Isfahan, Iran.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vincenzo Salpietro
Mansour Salehi
From the Department of Neuromuscular Disorders Institute of Neurology (R.M., R.K., V.S., H.H.), University College London, Queen Square; and Medical Genetics Laboratory of Genome (M.B., M.S.), Isfahan, Iran.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mansour Salehi
Henry Houlden
From the Department of Neuromuscular Disorders Institute of Neurology (R.M., R.K., V.S., H.H.), University College London, Queen Square; and Medical Genetics Laboratory of Genome (M.B., M.S.), Isfahan, Iran.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Henry Houlden
Full PDF
Citation
Further supporting evidence for REEP1 phenotypic and allelic heterogeneity
Reza Maroofian, Mahdiyeh Behnam, Rauan Kaiyrzhanov, Vincenzo Salpietro, Mansour Salehi, Henry Houlden
Neurol Genet Dec 2019, 5 (6) e379; DOI: 10.1212/NXG.0000000000000379

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
17

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Heterozygous mutations in REEP1 (MIM #609139) encoding the receptor expression-enhancing protein 1 (REEP1) are a well-recognized and relatively frequent cause of autosomal dominant hereditary spastic paraplegia (HSP), SPG31.1 REEP1 localizes in the mitochondria and endoplasmic reticulum (ER) and facilitates ER-mitochondria interactions.2 In addition to the HSP phenotype, REEP1 has been associated with an autosomal dominant spinal type of Charcot-Marie-Tooth disease in 2 families.3 More recently, a patient with homozygous REEP1 mutation with a much more severe phenotype akin to spinal muscular atrophy with respiratory distress type 1 (SMARD1) was reported.4 In this report, we present a patient with a homozygous mutation in REEP1 manifesting a severe congenital distal spinal muscular atrophy (SMA) with diaphragmatic paralysis, expanding the phenotype from mild autosomal dominant HSP through to severe recessive distal SMA pattern.

Clinical report

The proband is a 14-year-old girl who is the product of a normal full-term pregnancy. Her parents are healthy first-cousin Iranians in their mid-thirties. At birth, she presented with proximal and distal muscle weakness in all the limbs with flexion contractures at the knees and elbows, foot drop, and progressive wrist drop (figure1, B–F, Video 1). She could crawl, hold her head erect at normal age, and sit at the age of 5 months. Afterward, there has been a marked regression in neurologic development, resulting in permanent inability to stand up and/or walk and in severe recurrent contractions in hands and feet despite surgery being started from the age of 2.5 years. She developed progressive muscular atrophy starting from the lower limbs and progressing to the upper limbs. At the age of 3 years, she was diagnosed with diaphragmatic palsy, resulting in fever-associated breathing difficulties. She was also diagnosed with esophageal sphincter palsy, which was corrected by surgery. Her cognition and speech are preserved, and she does not have visual or hearing impairment.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure Clinical images and molecular genetic findings of the case

(A) DNA chromatograms. The top row is a sequence from the father, the middle row is from the mother, and the bottom row is from the proband. The blue arrow points at A > G substitution, which is heterozygous in the parents and homozygous in the proband. (B–E) Distal and proximal arthrogryposis. Wasted limb muscles. (F) X-ray of the arms. Deformity of the middle phalanges and lateroflexion of the hand. (G) Family tree.

Video 1

The reported patient is sits, and this is followed by an attempt to crawl, and then, she rolled over. Proximal and distal arthrogryposis, flexed trunk and head, and mild facial dystonia are present. Mobility is severely impaired. Download Supplementary Video 1 via http://dx.doi.org/10.1212/000379_Video_1

On neurologic examination, she had marked plantar flexion contractures in the ankles and flexion contractions in the wrists, brisk deep tendon reflexes in the knees, absent Achilles reflex, no Babinski sign, and normal reflexes in the upper limbs. There was low muscle tone and wasting in the limbs. Neurophysiology studies showed signs of severe sensory and moderate motor axonal degeneration, fibrillations, and marked reduction in the motor unit interference pattern with an increase in amplitude and duration of motor unit action potentials in the right and left tibialis anterior muscles. The latter change was also observed to a lesser degree in the right biceps and left deltoid. Sural nerve biopsy was compatible with chronic demyelinating neuropathy with secondary focal axonal and nerve fibers loss. Brain MRI was unremarkable. Dosage and Sanger sequencing of the SMN1 gene was performed and resulted negative. The clinical diagnosis of distal SMA with diaphragmatic paralysis was made. Single-nucleotide polymorphism array genotyping in combination with exome sequencing revealed a homozygous pathogenic missense variant in REEP1 (NM_022912: c.124T > C; p.Trp42Arg) within a 59 Mb homozygosity region (figure1A).

Discussion

The p.Trp42Arg REEP1 variant has been previously reported as pathogenic in autosomal dominant hereditary spastic paraplegia.5 The mutation leads to haploinsufficiency and interferes with the integrity of the N-terminus of REEP1 and impairs normal ER targeting and shaping.6 It has been speculated in a Drosophila model that REEP1-associated disorders could be ER stress diseases expressing variable phenotypes depending on the type of impaired function in the ER.4 Furthermore, REEP1 could have a direct role in the control of mitochondrial network morphology through interaction with the crucial protein involved in mitochondrial fission, named DRP1. It has been shown that important alterations take place in the mitochondrial morphology in the primary fibroblasts of patients with REEP1 HSP compared with control cells.7

To date, only 1 homozygous mutation has been reported in REEP1; this affects a splice donor site (p.Phe62Lysfs23*) and was found in a Lebanese patient presenting with a SMARD1-like phenotype which included distal arthrogryposis, congenital axonal neuropathy, hyperreflexia, and respiratory distress, but without any cognitive or language impairment.4 Although there was a significant phenotypic overlap between this reported individual and our patient, arthrogryposis involving proximal and distal joints was more pronounced in our patient, whereas diaphragmatic palsy seems to be more severe in the homozygous p.Phe62Lysfs23* carrier. In addition, our case adds data on peculiar electromyographic changes that were not reported in the former report. Of interest, parents were carriers of the variant in the heterozygous state, already associated with complex autosomal dominant hereditary spastic paraplegia, and neither gait problems nor family history of HSP was reported by them. REEP1 heterozygous mutations express incomplete penetrance predominantly manifesting before the age of 20 years or after the age of 30 years.8 Unfortunately, the parents did not have neurologic and electrophysiologic examinations to exclude the subclinical or mild forms of HSP. The incomplete penetrance of the p.Trp42Arg variant in the heterozygous state could be explained by the effects of modifying genes and stochastic processes during development.4

The identification of 2 different biallelic REEP1 mutations in patients with SMARD1-like phenotypes and respiratory Distress expand the phenotypic spectrum associated to this gene and demonstrates the loss-of-function dosage effect and implications of the same allele in distinct neurologic phenotypes.

Study funding

This study was funded by Wellcome Trust and the Medical Research Council.

Disclosure

Disclosures available: Neurology.org/NG.

Appendix Authors

Footnotes

  • Go to Neurology.org/NG for full disclosures. Funding information is provided at the end of the article.

  • ↵* These authors contributed equally to the manuscript.

  • The Article Processing Charge was funded by Wellcome Trust and MRC UK.

  • Received April 8, 2019.
  • Accepted in final form October 15, 2019.
  • Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

References

  1. 1.↵
    1. Züchner S,
    2. Wang G,
    3. Tran-Viet KN, et al
    . Mutations in the novel mitochondrial protein REEP1 cause hereditary spastic paraplegia type 31. Am J Hum Genet 2006;79:365–369.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Lim Y,
    2. Cho IT,
    3. Schoel LJ,
    4. Cho G,
    5. Golden JA
    . Hereditary spastic paraplegia-linked REEP1 modulates endoplasmic reticulum/mitochondria contacts. Ann Neurol 2015;78:679–696.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Bock A,
    2. Günther S,
    3. Mohr J, et al
    . A nonstop variant in REEP1 causes peripheral neuropathy by unmasking a 3′UTR-encoded, aggregation-inducing motif. Hum Mutat 2018;39:193–196.
    OpenUrl
  4. 4.↵
    1. Schottmann G,
    2. Seelow D,
    3. Seifert F, et al
    . Recessive REEP1 mutation is associated with congenital axonal neuropathy and diaphragmatic palsy. Neurol Genet 2015;1:e32.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Goizet C,
    2. Depienne C,
    3. Benard G, et al
    . REEP1 mutations in SPG31: frequency, mutational spectrum, and potential association with mitochondrial morpho-functional dysfunction. Hum Mutat 2011;32:1118–1127.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Falk J,
    2. Rohde M,
    3. Bekhite M, et al
    . Functional mutation analysis provides evidence for a role of REEP1 in lipid droplet biology. Hum Mutat 2014;35:497–504.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Lavie J,
    2. Serrat R,
    3. Bellance N, et al
    . Mitochondrial morphology and cellular distribution are altered in SPG31 patients and are linked to DRP1 hyperphosphorylation. Hum Mol Genet 2017;26:674–685.
    OpenUrl
  8. 8.↵
    1. Beetz C,
    2. Schule R,
    3. Deconinck T, et al
    . REEP1mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31. Brain 2008;131:1078–1086.
    OpenUrlCrossRefPubMed
View Abstract

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All contributors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.ng.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Letters

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Letters Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Clinical report
    • Discussion
    • Study funding
    • Disclosure
    • Appendix Authors
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures

Related Articles

  • No related articles found.

Topics Discussed

  • All Genetics
  • Spastic paraplegia

Alert Me

  • Alert me when this article is cited
  • Alert me if a correction is posted
  • Alert me when eletters are published
Advertisement
Neurology Genetics: 5 (6)

Articles

  • Articles
  • Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Genetics | Online ISSN: 2376-7839

© 2019 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise